Skip to main content
JINLING PHARMACEUTICAL CO.,LTD logo

JINLING PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000919 ISIN · CNE0000010W5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,771 across all filing types
Latest filing 2021-06-21 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000919

About JINLING PHARMACEUTICAL CO.,LTD

https://www.jlyy1999.com

Jinling Pharmaceutical Co., Ltd. specializes in the research, development, manufacture, and sale of pharmaceutical products, with a focus on chemical drugs and traditional Chinese medicine preparations. The company’s product portfolio primarily targets cardiovascular and cerebrovascular diseases, anti-tumor treatments, and digestive system health. A prominent product in its lineup is the Mailuoning Injection, utilized for treating various vascular conditions. In addition to its manufacturing operations, the company is involved in the management and operation of medical institutions, integrating clinical services with pharmaceutical production. Its business model emphasizes the synergy between drug development and healthcare service delivery to provide integrated medical solutions.

Recent filings

Filing Released Lang Actions
金陵药业股份有限公司2020年年度股东大会法律意见书-20210621
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2020 Annual General Meeting (AGM) of Jinling Pharmaceutical Co., Ltd. It details the procedures of the AGM, attendance, voting results on various proposals including the 2020 annual report and financial statements, and confirms the legality and validity of the meeting and its resolutions. The document is not the actual annual report or financial statements but a legal opinion on the AGM and its voting results. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes of the AGM.
2021-06-21 Chinese
金陵药业股份有限公司2020年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2020 Annual General Meeting (AGM) resolution announcement for Jinling Pharmaceutical Co., Ltd. It details the date, attendance, voting results on various proposals including the 2020 annual reports, financial statements, profit distribution plan, and appointment of auditors. It also includes legal opinions on the meeting's validity. The document is a formal announcement of the resolutions passed at the AGM rather than the full AGM materials or the annual report itself. The length is under 5,000 characters and it primarily reports voting outcomes and meeting details. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-06-21 Chinese
金陵药业股份有限公司关于召开2020年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2020 Annual General Meeting (AGM) of Jinling Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures, agenda items including the 2020 annual reports and financial statements, and proxy voting instructions. The document does not contain the actual annual report or financial statements but rather the announcement and procedural details for the AGM. The length is about 6,000 characters, which is consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2021-05-28 Chinese
金陵药业股份有限公司第八届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the ninth meeting of the eighth board of directors of Jinling Pharmaceutical Co., Ltd. It details the meeting date, voting results, and references the upcoming 2020 annual general meeting (AGM) notice. The content focuses on board meeting procedures and decisions rather than presenting financial data or full reports. It is not an annual report, earnings release, or financial statement. The document is an announcement related to board/management activities, specifically a board meeting resolution. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear keywords like '董事会会议决议公告' (board meeting resolution announcement) and detailed voting results at a board meeting.
2021-05-28 Chinese
金陵药业股份有限公司关于增补公司职工监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement from the supervisory board of Jinling Pharmaceutical Co., Ltd. regarding the resignation of an employee supervisor and the election of a new employee supervisor to the supervisory board. It includes biographical details and compliance statements about the new supervisor. There is no financial data, no report attached or referenced, and no mention of annual or interim reports, earnings, or other financial filings. This is a management or board-related announcement about changes in supervisory board personnel, fitting the category of Board/Management Information (MANG). The document length is short and focused solely on this personnel change, confirming it is not a report or announcement of a report publication.
2021-05-24 Chinese
金陵药业股份有限公司关于公司职工监事辞职的公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the resignation of an employee supervisor from the company's supervisory board. It includes no financial data, no report attachments, and no mention of financial results or regulatory filings. It is an announcement about a change in the company's board-level personnel (supervisory board member). Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2021-05-17 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.